16
Nov
2023
14:00
GMT
09:00
EST
Webinar
Expert Insights into Challenging Cardio-Oncology Cases
-
Views:
1174
-
Likes:
9
Overview
Prof Daniel Lenihan (Saint Francis Healthcare System, Cape Girardeau, US), Prof Joe Carver (Abramson Cancer Center of the University of Pennsylvania, Philadelphia, US) and Prof Joshua Mitchell (Washington University School of Medicine, St Louis, US) are renowned for their ground-breaking contributions to this field, bring decades of clinical experience and research to the table, making this an exceptional opportunity to learn, engage and unravel the complexities of Cardio-Oncology.
The partnership combines Radcliffe’s rapidly growing global community and expertise in delivering the most innovative virtual events, with the knowledge and experience of IC-OS’s members, to curate broadcasts that challenge current practice and have real-world patient benefits.
This broadcast is for cardiologists, haematologists, oncologists, nurse practitioners, nurses and pharmacists.
The International Cardio-Oncology Society is a committed group of professionals throughout the world who are striving to protect the cardiovascular health of all patients who are undergoing cancer therapy. By optimising the cardiac status of patients with cancer before, during and after their treatment, IC-OS is collectively improving the overall outcomes including survival and quality of life. IC-OS aims to provide the latest scientific and clinical education and research for anyone treating patients with cancer in the hopes of enhancing cardiovascular protection.
Support Statement
This is an independent activity run by the International cardio-oncology Society (ICOS) and co-produced in collaboration with Radcliffe Cardiology. IC-OS has been provided support to deliver this webinar series by AstraZeneca, BMS/Pfizer Alliance, Eli Lilly and Roche through an unrestricted educational grant to cover organisational costs and has had no input into the agenda or content of this educational activity. Radcliffe Cardiology has received no industry funding.
Faculty:
Dan Lenihan
Joe Carver
Joshua Mitchell
This broadcast is supported by
Faculty Biographies
Dan Lenihan
Dr Dan Lenihan is a cardio-oncologist specialising in cardiology, heart disease and advanced heart failure, at Saint Francis Healthcare System, Cape Girardeau, US.
He is a co-Founder and Board Member of the International Cardio-Oncology Society (ICOS), which is an international professional association whose primary goal is to eliminate cardiac disease as a barrier to effective cancer therapy.
He is actively involved in patient care as the Director of the Cardio-Oncology Programme, Cardiac Rehabilitation, and the Heart Failure clinic at Saint Francis Healthcare System.
Joe Carver
Dr Joe Carver is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, Philadelphia, US. He is the Chief of Staff at the Abramson Cancer Center.
He is the Director of the Thalheimer Cardio-oncology Center at the Abramson Cancer Center and his clinical practice is in the subspecialty of cardio-oncology.
Joshua Mitchell
Dr Joshua Mitchell, MD, MSCI is an Associate Professor of Medicine, Director of the Cardio-Oncology Centre of Excellence and the Cardio-Oncology Fellowship at Washington University School of Medicine in St. Louis, US. He also serves as Co-Director of the Amyloid Centre of Excellence.
Before joining Washington University in 2015, Dr Mitchell dedicated 11 years to the Army, serving as a Field Artillery Officer and a physician with the 82nd Airborne Division and the 75th Ranger Regiment, achieving the rank of Major and earning two Bronze Star Medals.
In addition to his roles at Washington University, Dr Mitchell is a member of the editorial boards for JACC: Cardio-Oncology and the American Journal of Medicine. He chairs the IC-OS Patient Advocacy working group and is a member of the IC-OS Scientific Committee, having previously chaired the 2021 IC-OS expert consensus statement for cardiovascular disease screening in radiation survivors.
Dr Mitchell's clinical and research interests focus on understanding cardiovascular disease associated with cancer treatment and the diagnosis and management of cardiac amyloidosis. His research also explores the use of coronary artery calcium to enhance risk prediction and target preventive therapy.